Skip To Main Content
Paul Nghiem on Muck Rack

Paul Nghiem

Seattle
As seen in: MSN, Nature, PNAS, JAMA (The Journal of the American Medical Association), JAMA Network, JAMA Oncology, The New England Journal of Medicine, Medical Xpress, Prevention, HemOnc Today and
Dermatologist/cancer biologist. Runs lab using immune system to fight a nasty virus-driven skin cancer. Two boys, a pandemic puppy & chamber music for fun.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence

|
By Manisha Thakuria, Tomoko Akaike, Ann W. Silk, Daniel Hippe, Peter Y. Ch’en, Rian Alam, Joshua Chan, Karam Khaddour, Austin J Jabbour, Alex Z. Fu, Hannah Kim, Nicole M. Urman, Evan Hall, Shailender Bhatia, Paul Nghiem, Lisa C. Zaba, Kate B. Biese, Macy W. Gilmour, Ariel Finberg, Meliea W. Chiu
| JAMA Network Verified
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence Key Points Question When monitoring for recurrent Merkel cell carcinoma, which blood-based test is more accurate: circulating tumor DNA (ctDNA) or Merkel cell polyomavirus antibody testing?
Open in Who Shared Issue with article?

What’s Next in Dermatology? Dermatologists Weigh In On 2026

|
By Linda Gold, Lawrence F. Eichenfield, Neal Bhatia, Dawn Z. Eichenfield, Philip Mease, Paul Nghiem, Walter Liszewski
| consultantlive.com
As 2026 begins, clinicians in dermatology are looking ahead to a year defined by expanding oral therapeutics, immunologic insights, next-generation biologics, and the increasing artificial intelligence (AI) integration into clinical settings. At the 2026 Maui Derm Hawaii meeting, the HCPLive team spoke on-site with several leaders in the field of skin health about new data and therapeutic advances they anticipate shaping the field in the year ahead.
Open in Who Shared View Duplicates (2) Issue with article?

CLINICAL BENEFIT OF ADDING RADIATION FOR IMMUNE CHECKPOINT INHIBITOR-REFRACTORY MERKEL CELL CARCINOMA: A 27-PATIENT ANALYSIS

|
By Seattle WA, Albert Einstein College, Paul Nghiem
| jidonline.org
Keywords Merkel cell carcinoma Immunotherapy radiation therapy combination therapy Abbreviations MCC (Merkel cell carcinoma) ICI (immune checkpoint inhibitor) RT (radiation therapy) PFS (progression-free survival) HR (hazard ratio) Gy (Gray) OS (overall survival) CR (complete response) PR (partial response) PD (progressive disease) SD (stable disease) AE (adverse events) Get full text access Log in, subscribe or purchase for full access. References 1. Becker, J.C. ∙ Stang, A. ∙ DeCaprio, J.A. ...
Open in Who Shared Issue with article?
See all 28 licensed articles (37 Total)